New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany
Objectives To validate the newly developed Daily Experience Sampling Questionnaire (DESQ) that measures affective subjective well-being (SWB). The DESQ is an end-of-day diary in which respondents retrospectively rate their SWB at six different, randomly determined moments; it is completed over 1 wee...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/12/e039227.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846160665828392960 |
|---|---|
| author | Matthias Augustin Natalia Kirsten Ibrahim Nergiz Ulrich Schiffner Marina Otten |
| author_facet | Matthias Augustin Natalia Kirsten Ibrahim Nergiz Ulrich Schiffner Marina Otten |
| author_sort | Matthias Augustin |
| collection | DOAJ |
| description | Objectives To validate the newly developed Daily Experience Sampling Questionnaire (DESQ) that measures affective subjective well-being (SWB). The DESQ is an end-of-day diary in which respondents retrospectively rate their SWB at six different, randomly determined moments; it is completed over 1 week. The DESQ shall provide an alternative or complementary approach to existing methods of near-time SWB measurement (experience sampling, Day Reconstruction Method). The primary research objective was to determine criterion validity of the DESQ.Design Prospective, non-interventional study.Setting Participants were recruited in Hamburg, Germany, at a specialised outpatient clinic (patients) and via different channels (healthy participants).Participants 101 adults with diagnosed and stable psoriasis (46 women, 55 men); 105 adults without psoriasis (49 women, 56 men).Primary and secondary outcome measures Participants completed the DESQ for 3 weeks. In weeks 2 and 3, they also performed experience sampling. Criterion validity was determined by weekwise intraclass correlations (ICC) between both methods. Sensitivity to change was determined by the correlation between changes in both methods from weeks 2 to 3. For convergent validity, related concepts such as life satisfaction were measured. Retest reliability was determined using DESQ values of weeks 2 and 3.Results Criterion validity was excellent (ICC: patients=0.86, 95% CI 0.81 to 0.91; healthy participants=0.86, 95% CI 0.79 to 0.91). Sensitivity to change was r=0.57 and r=0.56, respectively. Correlations with convergent criteria were mostly significant and higher in constructs more proximal to SWB. The ICC indicating retest reliability was 0.77 in patients (95% CI 0.68 to 0.84) and 0.81 in healthy participants (95% CI 0.73 to 0.86).Conclusions The DESQ is a valid, reliable and feasible instrument for SWB measurement in people with psoriasis and healthy people. Its approach of end-of-day evaluations of single moments may also lend itself to the measurement of other highly time-variant constructs such as pain, fatigue or depression. |
| format | Article |
| id | doaj-art-1999d62df47d49f59e03b4c3154347e1 |
| institution | Kabale University |
| issn | 2044-6055 |
| language | English |
| publishDate | 2020-12-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | BMJ Open |
| spelling | doaj-art-1999d62df47d49f59e03b4c3154347e12024-11-22T03:25:07ZengBMJ Publishing GroupBMJ Open2044-60552020-12-01101210.1136/bmjopen-2020-039227New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in GermanyMatthias Augustin0Natalia Kirsten1Ibrahim Nergiz2Ulrich Schiffner3Marina Otten4Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyCenter for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyCenter for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyInstitute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, GermanyObjectives To validate the newly developed Daily Experience Sampling Questionnaire (DESQ) that measures affective subjective well-being (SWB). The DESQ is an end-of-day diary in which respondents retrospectively rate their SWB at six different, randomly determined moments; it is completed over 1 week. The DESQ shall provide an alternative or complementary approach to existing methods of near-time SWB measurement (experience sampling, Day Reconstruction Method). The primary research objective was to determine criterion validity of the DESQ.Design Prospective, non-interventional study.Setting Participants were recruited in Hamburg, Germany, at a specialised outpatient clinic (patients) and via different channels (healthy participants).Participants 101 adults with diagnosed and stable psoriasis (46 women, 55 men); 105 adults without psoriasis (49 women, 56 men).Primary and secondary outcome measures Participants completed the DESQ for 3 weeks. In weeks 2 and 3, they also performed experience sampling. Criterion validity was determined by weekwise intraclass correlations (ICC) between both methods. Sensitivity to change was determined by the correlation between changes in both methods from weeks 2 to 3. For convergent validity, related concepts such as life satisfaction were measured. Retest reliability was determined using DESQ values of weeks 2 and 3.Results Criterion validity was excellent (ICC: patients=0.86, 95% CI 0.81 to 0.91; healthy participants=0.86, 95% CI 0.79 to 0.91). Sensitivity to change was r=0.57 and r=0.56, respectively. Correlations with convergent criteria were mostly significant and higher in constructs more proximal to SWB. The ICC indicating retest reliability was 0.77 in patients (95% CI 0.68 to 0.84) and 0.81 in healthy participants (95% CI 0.73 to 0.86).Conclusions The DESQ is a valid, reliable and feasible instrument for SWB measurement in people with psoriasis and healthy people. Its approach of end-of-day evaluations of single moments may also lend itself to the measurement of other highly time-variant constructs such as pain, fatigue or depression.https://bmjopen.bmj.com/content/10/12/e039227.full |
| spellingShingle | Matthias Augustin Natalia Kirsten Ibrahim Nergiz Ulrich Schiffner Marina Otten New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany BMJ Open |
| title | New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany |
| title_full | New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany |
| title_fullStr | New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany |
| title_full_unstemmed | New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany |
| title_short | New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany |
| title_sort | new method of measuring subjective well being prospective validation study of the daily experience sampling questionnaire desq in patients with psoriasis and healthy subjects in germany |
| url | https://bmjopen.bmj.com/content/10/12/e039227.full |
| work_keys_str_mv | AT matthiasaugustin newmethodofmeasuringsubjectivewellbeingprospectivevalidationstudyofthedailyexperiencesamplingquestionnairedesqinpatientswithpsoriasisandhealthysubjectsingermany AT nataliakirsten newmethodofmeasuringsubjectivewellbeingprospectivevalidationstudyofthedailyexperiencesamplingquestionnairedesqinpatientswithpsoriasisandhealthysubjectsingermany AT ibrahimnergiz newmethodofmeasuringsubjectivewellbeingprospectivevalidationstudyofthedailyexperiencesamplingquestionnairedesqinpatientswithpsoriasisandhealthysubjectsingermany AT ulrichschiffner newmethodofmeasuringsubjectivewellbeingprospectivevalidationstudyofthedailyexperiencesamplingquestionnairedesqinpatientswithpsoriasisandhealthysubjectsingermany AT marinaotten newmethodofmeasuringsubjectivewellbeingprospectivevalidationstudyofthedailyexperiencesamplingquestionnairedesqinpatientswithpsoriasisandhealthysubjectsingermany |